大博医疗: 关于持股5%以上股东股份减持计划的预披露公告

Core Viewpoint - The major shareholder, Dabo Medical International Investment Co., Ltd., plans to reduce its stake in Dabo Medical Technology Co., Ltd. by up to 8,280,390 shares, representing 2.00% of the current total share capital, within three months starting from 15 trading days after the announcement [1][2]. Group 1: Shareholder Information - Dabo Medical International holds 82,926,901 shares, accounting for 20.03% of the current total share capital of 414,019,506 shares, and 20.39% when excluding repurchased shares [1][2]. - The shareholder has committed to providing accurate and complete information regarding the share reduction plan [1]. Group 2: Reduction Plan Details - The reduction will occur through centralized bidding or block trading, with a maximum of 8,280,390 shares to be sold, which is 2.00% of the total share capital [2]. - The reduction period is set from December 18, 2025, to March 17, 2026, and will comply with relevant legal regulations [2][3]. - Any changes in the company's share structure, such as stock dividends or capital increases, will lead to adjustments in the planned reduction amount [2]. Group 3: Compliance with Previous Commitments - The current reduction plan aligns with previously disclosed intentions and commitments regarding shareholding and reduction [3][4]. - Dabo International has adhered to its commitments since the company's initial public offering, ensuring no violations of prior agreements [4].